Clinical Trials Logo
  1. Home
  2. Glomerulonephritis, Membranous
  3. NCT05914155

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome — PRIME  

Glomerulonephritis, Membranous Clinical Trial

Official title:
The Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rituximab (Genetical Recombination) for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome （PRIME Study）

Clinical Trial Summary

To confirm the efficacy and safety of rituximab (genetical recombination) intravenously administered to idiopathic membranous nephropathy with nephrotic syndrome.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05914155
Study type Interventional
Source Nagoya University
Contact Shoichi Maruyama, PhD, MD
Phone +81527442192
Email marus@med.nagoya-u.ac.jp
Status Recruiting
Phase Phase 3
Start date June 24, 2023
Completion date December 31, 2026
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01129557 - Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease Phase 4
Completed NCT00199628 - Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Active, not recruiting NCT05656963 - The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD
Completed NCT04145440 - Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) Phase 1/Phase 2
Terminated NCT04154787 - Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy Phase 2
Completed NCT00404794 - A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis Phase 3
Completed NCT03880643 - Rituximab in Refractory Primary Membranous Nephropathy
Not yet recruiting NCT05797051 - Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases
Completed NCT00135967 - Mycophenolate Mofetil in Membranous Nephropathy Phase 2/Phase 3
Completed NCT00843856 - Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis Phase 4
Recruiting NCT01282073 - Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy Phase 3
Completed NCT00135954 - Treatment of Patients With Idiopathic Membranous Nephropathy Phase 3
Completed NCT01610492 - A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy Phase 2
Active, not recruiting NCT03018535 - Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy Phase 3
Completed NCT00404833 - Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental Phase 3
Withdrawn NCT01762852 - Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy Phase 2